1. Global burden for dengue and the evolving pattern in the past 30 years;Yang;J Travel Med,2021
2. A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans;Nivarthi;Nat Commun,2021
3. Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine?;Whitehead;Expert Rev Vaccines,2016
4. Stimulation of B cell immunity in flavivirus-naive individuals by the tetravalent live attenuated dengue vaccine TV003;Tu;Cell Rep Med,2020
5. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial;Walsh;Lancet Infect Dis,2023